Eric Joseph
Stock Analyst at Citi
(4.46)
# 1,116
Out of 4,534 analysts
331
Total ratings
51.6%
Success rate
11.4%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma | Rated: Hold | $82 → $93 | $80.76 | +15.16% | 4 | Jul 17, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $380 | $272.67 | +39.36% | 3 | Jul 16, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $80 → $76 | $59.11 | +28.57% | 5 | Jul 16, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $99 | $79.11 | +25.14% | 3 | Jul 16, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | $90 → $100 | $52.95 | +88.86% | 3 | Jul 10, 2026 | |
| PTCT PTC Therapeutics | Initiated Coverage: Buy | $67 → $108 | $78.01 | +38.44% | 31 | Jun 10, 2026 | |
| ASND Ascendis Pharma | Initiated Coverage: Buy | $355 | $251.76 | +41.01% | 1 | May 15, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | $46 → $49 | $53.96 | -9.19% | 18 | Nov 3, 2025 | |
| PLRX Pliant Therapeutics | Downgraded: Sell | n/a | $1.07 | - | 7 | Oct 10, 2025 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $48 | $26.33 | n/a | 20 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $64 | $111.06 | n/a | 11 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $44 → $7 | $3.43 | n/a | 20 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $7.88 | n/a | 23 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.05 | n/a | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $18 | $3.32 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $32.21 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $11 | $19.18 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $9.23 | n/a | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.20 | n/a | 1 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $12 | $23.48 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $21 | $5.73 | n/a | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $70 | $180.39 | n/a | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 → $5 | $13.16 | n/a | 13 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $22.71 | n/a | 11 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $1.31 | n/a | 11 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $7 | $3.58 | n/a | 6 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $10 | $2.89 | n/a | 6 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $5 | $12.92 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $5 | $2.19 | n/a | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $4.78 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $1.40 | n/a | 4 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $22.16 | n/a | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $7.47 | n/a | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $3.85 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $5.28 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $7 | $1.81 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.28 | n/a | 5 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $11 | $7.36 | n/a | 3 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.63 | n/a | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.000001 | n/a | 3 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $39 → $26 | $41.12 | n/a | 3 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.07 | n/a | 1 | Feb 7, 2020 |
BridgeBio Pharma
Jul 17, 2026
Rated: Hold
Price Target: $82 → $93
Current: $80.76
Upside: +15.16%
Alnylam Pharmaceuticals
Jul 16, 2026
Maintained: Buy
Price Target: $380
Current: $272.67
Upside: +39.36%
BioMarin Pharmaceutical
Jul 16, 2026
Maintained: Buy
Price Target: $80 → $76
Current: $59.11
Upside: +28.57%
Cytokinetics
Jul 16, 2026
Maintained: Buy
Price Target: $99
Current: $79.11
Upside: +25.14%
Ionis Pharmaceuticals
Jul 10, 2026
Maintained: Buy
Price Target: $90 → $100
Current: $52.95
Upside: +88.86%
PTC Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $67 → $108
Current: $78.01
Upside: +38.44%
Ascendis Pharma
May 15, 2026
Initiated Coverage: Buy
Price Target: $355
Current: $251.76
Upside: +41.01%
TG Therapeutics
Nov 3, 2025
Maintained: Buy
Price Target: $46 → $49
Current: $53.96
Upside: -9.19%
Pliant Therapeutics
Oct 10, 2025
Downgraded: Sell
Price Target: n/a
Current: $1.07
Upside: -
Beam Therapeutics
Jun 25, 2025
Reiterated: Buy
Price Target: $48
Current: $26.33
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: $57 → $64
Current: $111.06
Upside: n/a
May 28, 2025
Downgraded: Hold
Price Target: $44 → $7
Current: $3.43
Upside: n/a
May 19, 2025
Reiterated: Sell
Price Target: $7
Current: $7.88
Upside: n/a
May 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $3.05
Upside: n/a
May 16, 2025
Maintained: Buy
Price Target: $22 → $18
Current: $3.32
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: n/a
Current: $32.21
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $21 → $11
Current: $19.18
Upside: n/a
May 7, 2025
Maintained: Hold
Price Target: $14
Current: $9.23
Upside: n/a
Apr 25, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.20
Upside: n/a
Mar 20, 2025
Maintained: Buy
Price Target: $15 → $12
Current: $23.48
Upside: n/a
Mar 4, 2025
Maintained: Buy
Price Target: $20 → $21
Current: $5.73
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $71 → $70
Current: $180.39
Upside: n/a
Feb 10, 2025
Maintained: Sell
Price Target: $9 → $5
Current: $13.16
Upside: n/a
Jan 29, 2025
Maintained: Buy
Price Target: $31 → $30
Current: $22.71
Upside: n/a
Dec 17, 2024
Reiterated: Hold
Price Target: $11
Current: $1.31
Upside: n/a
Feb 23, 2024
Maintained: Hold
Price Target: $6 → $7
Current: $3.58
Upside: n/a
Nov 13, 2023
Maintained: Hold
Price Target: $11 → $10
Current: $2.89
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $15 → $5
Current: $12.92
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $28 → $5
Current: $2.19
Upside: n/a
Aug 10, 2023
Downgraded: Sell
Price Target: n/a
Current: $4.78
Upside: n/a
May 5, 2023
Maintained: Hold
Price Target: $6 → $5
Current: $1.40
Upside: n/a
Nov 29, 2022
Downgraded: Sell
Price Target: n/a
Current: $22.16
Upside: n/a
Nov 4, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $7.47
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $12 → $13
Current: $3.85
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $5.28
Upside: n/a
Mar 29, 2022
Maintained: Buy
Price Target: $24 → $7
Current: $1.81
Upside: n/a
Mar 4, 2022
Maintained: Sell
Price Target: n/a
Current: $1.28
Upside: n/a
Nov 11, 2021
Maintained: Hold
Price Target: $14 → $11
Current: $7.36
Upside: n/a
Oct 8, 2021
Downgraded: Sell
Price Target: n/a
Current: $9.63
Upside: n/a
Nov 9, 2020
Downgraded: Sell
Price Target: n/a
Current: $0.000001
Upside: n/a
Sep 21, 2020
Maintained: Hold
Price Target: $39 → $26
Current: $41.12
Upside: n/a
Feb 7, 2020
Reiterated: Hold
Price Target: n/a
Current: $5.07
Upside: n/a